172 nations are working together to make COVID-19 vaccine globally accessible: WHO

0
194
Disturbing Rates Of Antibiotic Resistance Who Warns Its Overuse On Covid-19 Patients - We The World Magazine
Image via @east_facts Twitter

In what is being said as an initiative to provide countries worldwide equitable access to safe and effective vaccines, 172 nations are now engaging to potentially participate in COVAX – a global pool for the COVID-19 vaccine.

However, more funds are needed and countries are now having to make bidding commitments in the vaccine plan, WHO said on Monday.

According to the announcement, ‘potential self-financing participants’ will have to pitch by August 31st and bid by September 18th.

“COVID-19 is an unprecedented global health challenge that can only be met with unprecedented cooperation between governments, researchers, manufacturers, and multilateral partners,” Dr. Tedros Adhanom Ghebreyesus, Director-General of WHO said in a media statement.

“By pooling resources and acting in solidarity through the ACT Accelerator and the COVAX Facility, we can ensure that once a vaccine is available for COVID-19, it’s available equitably to all countries.”

COVAX is the vaccine counterpart for the Access to COVID-19 Tools (ACT) Accelerator, which is a joint collaboration between the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO).

The facility aims to hoard and supply 2 billion doses of COVID-19 vaccine by the end of 2021 which will be made widely available. COVAX is the world’s only initiative that is working to bring equal vaccine access to both higher-income and lower-income nations.

WHO’s announcement comes amid hundreds of COVID-19 vaccines that are currently under development across the nations. However, WHO has raised alarm on ‘vaccine nationalism‘ where powerful nations prevent a free flow of potential vaccine against diseases from the wide world.

The global health body sees as a barrier that will prevent an equitable and fair distribution of the COVID-19 vaccine.